Clinical research, explained
What is a clinical trial — really?
8 min read · Reviewed by clinical staff · Last updated 2026-04-22
A clinical trial is a careful, regulated study of a treatment in volunteers — to learn whether it works, how well it works, and what side effects it has. Trials are how every approved drug, device, and procedure on the market today was tested before it reached patients.
Why trials exist
Before a treatment can be approved for general use, regulators require evidence that it is safe and that it works. That evidence comes from clinical trials — sequenced phases that test the treatment in increasingly larger groups of volunteers. Phase I is small and focused on safety. Phase II tests effectiveness in a few hundred patients. Phase III tests in thousands, comparing against the current standard of care. Phase IV continues monitoring after approval.
What participating means
Trial participants receive the investigational treatment (or, in randomized trials, sometimes the standard treatment for comparison) plus all the routine care the trial requires. They visit the trial site on a schedule for assessments, lab work, and imaging. The schedule is determined by the protocol — the document that defines exactly how the trial is run.
Participation is always voluntary. You can withdraw from any trial at any time, for any reason, without affecting your routine medical care. The site team will tell you what your options are if you decide to leave the trial.
Who runs a trial
Three groups: the sponsor (typically a pharmaceutical company or research institution that designs the trial and pays for it), the sites (the hospitals, clinics, and academic medical centers that recruit participants and run the visits), and the principal investigator at each site (the senior clinician legally responsible for trial conduct at that site). MyTrial connects participants to all three.
What happens after the trial ends
If the treatment works and is approved, you may have access to it through your regular doctor afterward. If the trial was inconclusive, the data is published and contributes to the broader scientific record — even “negative” results matter. If you experienced adverse events during the trial, the site team continues to monitor your safety for a defined follow-up window.